Nevertheless, our combined results of hsa-miR-873-5p-mediated repression of luciferase and endogenous GDF15 expression in two different cell types suggest that miR-873-5p may represent a novel therapeutic target for the treatment of cancers that exhibit increased activity of the GDF15 gene. Here, GDF15 is linked to cancer.